Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NTT Innovation Institute, Inc. (NTT i3) was the Silicon Valley-based research and development center for the NTT Group, established to accelerate the development of cloud computing, cybersecurity, and digital health technologies. In the healthcare sector, NTT i3 was recognized for its 'Global Health Platform,' a precision medicine initiative that integrated genomic data, electronic health records, and IoT device data to enable personalized care. The company collaborated with major academic institutions like UCSF to build digital health ecosystems and won industry awards for its work in reimagining personalized medicine through big data analytics and AI. NTT i3 also developed clinical trial data repositories and human monitoring solutions using wearable technologies. In 2019, the company was integrated into NTT Ltd. as part of a global reorganization of the NTT Group's business and R&D operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NTT i3.